2012, Number 3
<< Back Next >>
Finlay 2012; 2 (3)
Cognition and Comorbidity Behavior in Hospitalized Patients Suffering from Stroke. Seychelles 2010- 2011
Roca SAC, Henriette K
Language: Spanish
References: 37
Page: 137-145
PDF size: 589.12 Kb.
ABSTRACT
Background: cognitive impairment and high
comorbidity are common health problems in patients
with cerebrovascular disease.
Objective: to describe the behavior of cognitive
impairment and comorbidity in hospitalized patients
suffering from stroke.
Method: descriptive study of 77 patients with ischemic stroke admitted from April 2010 to December 2011, in Seychelles General Hospital. The behavior of this disease
in relation to variables such as age, presence of chronic
noncommunicable diseases, cognitive impairment, educational level, affected cerebral hemisphere and time of evolution was analyzed.
Results: 68,9 % of patients presented cognitive
impairment, their average age was 74,2 (± 9,19) years
old compared to 62,4 (± 14,2) years old for those with
no cognitive impairment. We found a higher frequency
of chronic noncommunicable diseases in cognitively
impaired patients with a Charlson comorbidity index of
2,11 (± 0,97). 18 patients with cognitive impairment and
Geriatrics. MSc. in Satisfactory Longevity. Assistant Professor.
Conclusions: more than half of hospitalized patients
experienced cognitive impairment and in most cases
previous to cerebrovascular disease. Male patients
predominated. There was an increase in age, severity of
depression, as well as in the frequency of chronic
noncommunicable diseases, and myocardial infarction of
considerable size, in respect to patients with no cognitive
impairment.
REFERENCES
Seshadri S, Beiser A, Kelly-Hayes M, Kase CS, Au R, Kannel WB, et al. The lifetime risk of stroke: estimates from the Framingham Study. Stroke. 2006;37(2):345-50.
Leys D, Hénon H, Mackowiak-Cordoliani MA, Pasquier F. Poststroke dementia. Lancet Neurol. 2005;4(11):752-9.
Snowdon DA, Greiner LH, Mortimer JA, Riley KP, Greiner PA, Markesbery WR. Brain infarction and the clinical expression of Alzheimer disease. The Nun Study. JAMA. 1997;277(10):813-7.
Marshall RS, Lazar RM. Pumps, aqueducts, and drought management: vascular physiology in vascular cognitive impairment. Stroke. 2011;42 (1):221-6.
Reitz C, Bos MJ, Hofman A, Koudstaal PJ, Breteler MB. Prestroke cognitive performance, incident stroke, and risk of dementia: the Rotterdam Study. Stroke. 2008;39(1):36-41.
Yesavage JA, Shelk JI. Geriatric Depression Scale (GDS):recent evidence and development of a shorter version. Clinical Gerontologist. 1986;5(1- 2):165-73.
Berkman LF, Leo-Summers L, Horwitz RI. Emotional support and survival after myocardial infarction. A prospective, population-based study of the elderly. Ann Intern Med. 1992;117(12):1003-9.
Adams HP, Bendixen BH, Kappelle LJ, Biller J, Love BB, Gordon DL, et al. Classification of subtype of acute ischemic stroke. Definitions for use in a multicenter clinical trial. TOAST. Trial of Org 10172 in Acute Stroke Treatment. Stroke. 1993;24(1):35- 41.
Serrano S, Domingo J, Rodríguez-García E, Castro MD, del Ser T. Frequency of cognitive impairment without dementia in patient with stroke: a twoyears follow-up study. Stroke. 2007;38(1):105-10.
Srikanth VK, Quinn SJ, Donnan GA, Saling MM, Thrift AG. Long-term cognitive transitions, rates of cognitive change, and predictors of incident dementia in a population-based first-ever stroke cohort. Stroke. 2006;37(10):2479-83.
Sachdev PS, Brodaty H, Valenzuela MJ, Lorentz L, Looi J, Berman K, et al. Clinical determinants of dementia and mild cognitive impairment following ischaemic stroke: the Sidney Stroke study. Dement Geriatr Cogn Disord. 2006;21(5-6):275-83.
Del Ser T, Barba R, Morin MM, Domingo J, Cemillan C, Pondal M, et al. Evolution of cognitive impairment after stroke and risk factors for delayed progression. Stroke. 2005;36(12):2670-5.
Melkas S, Oksala NK, Jokinen H, Pohjasvaara T, Vataja R, Oksala A, et al. Postroke dementia predicts poor survival in long-term follow-up: influence of prestrike cognitive decline and previous stroke. J Neurol Neurosurg Psychiatry. 2009;80 (8):865-70.
Fernández O, Rojas J, Pando A, Marrero M, Mesa Y, Santiesteban N, et al. Deterioro cognitivo después de un infarto cerebral: frecuencia y factores determinantes. Rev Neurol. 2008;46(6):326-30.
Ivan CS, Seshedri S, Beiser A, Au R, Kase CS, Kelly- Hayes M, et al. Dementia after stroke: the Framingham Study. Stroke. 2004;35(6):1264-8.
Barba R, Martínez S, Rodríguez E, Pondal M, Vivancos J, Del Ser T. Poststroke dementia. Clinical features and risk factors. Stroke. 2000;31(7):1494- 501.
Hébert R, Lindsay J, Verreault R, Rockwood K, Hill G, Dubois MF. Vascular dementia: incidence and risk factors in the Canadian study of health and aging. Stroke. 2000,31(7):1487-93.
Chau JP, Thompson DR, Twinn S, Chang AM, Woo J. Determinants of participation restriction among community dwelling stroke survivors: a path analysis. BMC Neurol. 2009;9:49.
De Weerd L, Rutgers WA, Groenier KH, van der Meer K. Perceived wellbeing of patients one year post stroke in general practice-recommendations for quality aftercare. BMC Neurol. 2011;11:42.
Hénon H, Pasquier F, Durieu I, Godefrey O, Lucas C, Lebert F, et al. Preexisting dementia in stroke patients. Baseline frequency, associated factors, and outcome. Stroke. 1997;28(12):2429-36.
Gorelick PB, Scuteri A, Black SE, DeCarli C, Greenberg SM, Iadecola C, et al. Vascular contributions to cognitive impairment and dementia: a statement for healthcare professionals from the American Heart Association/American Stroke Association. Stroke. 2011;42(9):2672–713.
Murray AM. Cognitive impairment in the aging dialysis and chronic kidney disease population: an occult burden. Adv Chronic Kidney Dis. 2008;15 (2):123-32.
Lavretsky H, Zheng L, Weiner MW, Mungas D, Reed B, Kramer JH, et al. Association of depressed mood and mortality in older adults with and without cognitive impairment in a prospective naturalistic Study. Am J Psychiatry. 2010;167(5):589-97.
Dickstein DL, Walsh J, Brautigam H, Stockton SD, Gandy S, Hof PR. Role of vascular risk factors and vascular dysfunction in Alzheimer’s disease. MT Sinai J Med. 2010;77(1):82-102.
Ericksson UK, Bennet AM, Gatz M, Dickman PW, Pedersen NL. Nonstroke cardiovascular disease and risk of Alzheimer disease and dementia. Alzheimer Dis Assoc Disord. 2010;24(3):213-9.
Craft S. The role of metabolic disorders in Alzheimer’s disease and vascular dementia: two roads converged. Arch Neurol. 2009;66(3):300-5.
Teper E, O’Brien JT. Vascular factors and depression. Int J Geriatr Psychiatry. 2008;23 (10):993-1000.
Chatterjee K, Fall S, Barer D. Mood after stroke: a case control study of biochemical, neuro-imaging and socio-economic risk factors for major depression in stroke survivors. BMC Neurol. 2010;10:125.
Park JH, Lee SB, Lee TJ, Lee DY, Jhoo JH, Youn JC, et al. Depression in vascular dementia is quantitatively and qualitatively different from depression in Alzheimer’s disease. Dement Geriatr Cogn Disord. 2007;23(2):67-73.
Aalten P, Verhey FR, Boziki M, Brugnolo A, Bullock R, Byrne EJ, et al. Consistency of neuropsychiatric syndromes across dementias: results from the European Alzheimer Disease Consortium. Part II. Dement Geriatr Cogn Disord. 2008;25(1):1-8.
Goldstein LB, Samsa GP, Matchar DB, Horner RD. Charlson index comorbidity adjustment for ischemic stroke outcome studies. Stroke. 2004;35(8):1941-5.
Tang J, Wan JY, Bailey JE. Performance of comorbidity measures to predict stroke and death in a community-dwelling, hypertensive Medicaid population. Stroke. 2008;39(7):1938-44.
Jia H, Zheng Y, Reker DM, Cowper DC, Wu SS, Vogel WB, et al. Multiple system utilization and mortality for veterans with stroke. Stroke. 2007;38 (2):355-60.
Volpato S, Maraldi C, Blé A, Ranzini M, Ritta Atti A, Dominquez LJ, et al. Prescription of antithrombotic therapy in older patients hospitalized for transient ischemic attack and ischemic stroke: The GIFA study. Stroke. 2004;35(4):913-7.
Liao YC, Liu RS, Lee ET, Lee YC, Wang PN, Lin KN, et al. Cognitive reserve: A SPECT study of 132 Alzheimer’s disease patients with an education range of 0-19 years. Dement Geriatr Cogn Disord. 2005;20(1):8-14.
Pendlebury ST, Rothwell PM. Prevalence, incidence, and factors associated with pre-stroke and poststroke dementia: a systematic review and metaanalysis. Lancet Neurol. 2009;8(11):1006–18.
Tang WK, Chan SS, Chiu HFK, Ungvari GS, Wong KS, Kwok CY, et al. Frequency and determinants of poststroke dementia in Chinese. Stroke. 2004;35 (4):930-5.